par de Azambuja, Evandro ;Cardoso, Fatima ;Meirsman, Livia;Straehle, Carolyn;Dolci, Stella;Vantongelen, Kris;Piccart-Gebhart, Martine
Référence Bulletin du cancer, 95, 3, page (352-357)
Publication Publié, 2008-03
Référence Bulletin du cancer, 95, 3, page (352-357)
Publication Publié, 2008-03
Article révisé par les pairs
Titre: |
|
Auteur: | de Azambuja, Evandro; Cardoso, Fatima; Meirsman, Livia; Straehle, Carolyn; Dolci, Stella; Vantongelen, Kris; Piccart-Gebhart, Martine |
Informations sur la publication: | Bulletin du cancer, 95, 3, page (352-357) |
Statut de publication: | Publié, 2008-03 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Altto |
Breast cancer | |
Lapatinib | |
Mindact | |
Neo-Altto | |
Trastuzumab | |
MeSH keywords: | Antibodies, Monoclonal -- therapeutic use |
Antineoplastic Agents -- therapeutic use | |
Breast Neoplasms -- chemistry | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- genetics | |
Female | |
Humans | |
International Cooperation | |
Microarray Analysis -- methods | |
Multicenter Studies as Topic | |
Organizational Objectives | |
Quinazolines -- therapeutic use | |
Randomized Controlled Trials as Topic | |
Receptor, erbB-2 -- analysis | |
Receptor, erbB-2 -- antagonists & inhibitors | |
Note générale: | English Abstract |
Journal Article | |
Review | |
Langue: | Français |
Identificateurs: | urn:issn:0007-4551 |
info:doi/10.1684/bdc.2008.0587 | |
info:pii/bdc.2008.0587 | |
info:scp/42149174337 | |
info:pmid/18390416 |